OnkoZert

What OnkoZert does

OnkoZert GmbH is an independent German certification institute founded in 2004 and headquartered in Neu-Ulm, operating as the mandate holder of the Deutsche Krebsgesellschaft (DKG, German Cancer Society). The company administers the certification system for organ cancer centers and oncology centers across DACH and select international markets, covering breast, colorectal, lung, prostate, gynecological, neuro-oncological, and numerous other cancer center types. With a team of approximately 50 employees and a wholly-owned IT subsidiary (ClarData GmbH), OnkoZert currently certifies more than 1,200 oncological care facilities.

The company's core technology stack centers on the OncoBox software platform, which calculates quality indicators for DKG-certified centers and is mandatory for colorectal and prostate cancer audits. The next-generation OncoBox 2.0 is being rolled out across modules (lung deployed in 2025, breast piloted in 2026), and a new Clara platform is under development with ClarData to manage certification procedures end-to-end. Supporting assets include OncoMap (public directory of certified centers), StudyBox (modular study documentation), PCO-Study (a prostate cancer outcomes study covering 47,466 evaluated patients across nine years), and the CovidDB clinical data application.

OnkoZert generates revenue through certification fees, recurring annual surveillance audits, expert auditor training programs (Fachexperten-Lehrgänge), and software-related services such as OncoBox Führerschein licensing courses. Certification cycles run three years, creating predictable multi-year contracts with healthcare-provider customers, and pricing is negotiated per scope rather than disclosed publicly. The go-to-market is direct B2B enterprise sales to hospitals and cancer centers, supplemented by international expansion through the European Cancer Centres (ECC) program, which has grown to nearly 100 participating facilities outside Germany.

Name

OnkoZert

Legal name

OnkoZert GmbH

Website

https://onkozert.de

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

OnkoZert is an independent German certification institute that operates as the mandate holder of the German Cancer Society (DKG), certifying over 1,200 oncological care facilities across DACH and select international markets through its OncoBox quality-indicator software and recurring audit services.

Ownership category

akta.pro rank

Headquarters

HQ city

Neu-ulm

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Certification Services: OnkoZert generates revenue through certification fees for oncological care facilities. As the mandate holder of the German Cancer Society, the company charges hospitals and medical centers for certification audits, document review, and ongoing surveillance audits. The certification validity period is 3 years, with annual surveillance audits creating recurring revenue streams.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

OnkoZert operates as the mandated certification institute of the German Cancer Society (DKG), administering certification, surveillance audits, and re-certification for organ-specific cancer centers (breast, colorectal, lung, prostate, gynecological, head and neck, neuro-oncology, etc.) and overarching oncology networks. It supports these processes with the OncoBox quality indicator software and OncoMap directory, and offers paid expert training courses (Fachexperten-Lehrgänge) for auditors and center coordinators.

Product overview

OnkoZert operates as an independent certification institute mandated by the German Cancer Society (DKG) to certify organ cancer centers and oncology centers. The product portfolio centers on the OncoBox software ecosystem for quality indicator calculation, which is mandatory for colorectal and prostate certifications. Related offerings include OncoMap (certified center directory), StudyBox (modular study documentation), PCO-Studie (prostate cancer outcome study), and EDium Study documentation platform. The company also developed the Clara platform with partner ClarData for certification procedure management. OnkoZert offers expert training programs and manages the certification audit process for over 1,200 oncological care facilities nationally and internationally.

Differentiator

Problem solved

Functional benefit

Brands

• OncoBox: Software tool developed by OnkoZert for calculating quality indicators of DKG-certified breast, colorectal, lung, and prostate cancer centers. The OncoBox 2.0 generation was introduced for lung cancer centers and is being developed for breast cancer centers.
• OncoMap
• StudyBox
• PCO-Studie
• Clara

Products and services

• DKG Certification Services Certification, annual surveillance audits, and re-certification of organ-specific cancer centers (breast, colorectal, lung, prostate, gynecological, head and neck, neuro-oncology, skin, uro-oncology, hematological neoplasia, pancreatic, and others) and overarching oncology networks, performed under DKG requirements on behalf of the German Cancer Society. Targeted at hospitals and medical centers in the DACH region and internationally.
• European Cancer Centres (ECC) International Certification International certification program managed via the European Cancer Centres network that enables oncological care facilities outside Germany to obtain DKG-aligned certification, covering nearly 100 facilities across international markets.
• Fachexperten-Lehrgänge (Expert Auditor Training) Paid professional expert training courses for qualifying as an auditor in the DKG certification system, covering multiple organ and center types. Targeted at physicians and quality experts seeking DKG auditor qualification.
• Audit Vor-/Nachbereitung Training Foundational training for personnel acting as central contact points in annual DKG certification audits (e.g., center coordination and quality management staff), covering audit preparation and follow-up steps including center-internal and external coordination.
• OncoBox Quality Indicator Software Software tool for calculating quality indicators of DKG-certified breast, colorectal, lung, and prostate cancer centers, with XML interface to tumor documentation systems. Mandatory for colorectal and prostate certifications; optional for breast and lung. Used by centers preparing for DKG certification audits.
• OncoBox Führerschein (Training Program) Scheduled paid training program for users of the OncoBox software, including OncoBox 2.0 modules, held quarterly (Q1 and Q2 2026 sessions announced) to train cancer center staff on effective use of the platform.
• StudyBox Clinical Study Documentation Platform Modular platform for standardized clinical study documentation, supporting structured data capture for multi-center studies. Targeted at clinical researchers and cancer centers participating in DKG-related studies.
• EDium Study Documentation Platform Modular documentation platform for clinical studies under the EDium Study brand, supporting standardized clinical data collection for multicenter research.
• Data Whitebox Data Standardization Platform Platform for data standardization and evaluation of clinical data, supporting consistent data formats and quality evaluation for research and certification purposes.
• PCO-Studie (Prostate Cancer Outcome Study) Patient outcome study focused on quality of life in prostate cancer patients, with over 100 DKG-certified prostate cancer centers participating and approximately 47,466 evaluated participants. OnkoZert provides the technological infrastructure for Germany, Austria, and Switzerland.
• FBREK Certification System (Familial Breast and Ovarian Cancer) Certification system for specialized centers focused on familial breast and ovarian cancer (FBREK), with its first pilot certificates awarded in 2021. Targeted at centers providing genetic counseling and preventive care for high-risk familial cancer patients.

Quantifiable outcome

• 1,200+ oncological care facilities certified nationally and internationally
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core, strategic and minor.

• ClarData GmbHcoreTechnology or IntegrationIT and data management partner responsible for technical infrastructure, software development (including Clara platform and OncoBox), and database management. ClarData handles the technological foundation for certification data processing and tumor documentation systems.
• Deutsche Krebsgesellschaft (DKG)coreStrategic or Co-development PartnerOnkoZert operates as mandate holder for the German Cancer Society, managing certification processes according to DKG requirements. The partnership defines the core business model where OnkoZert administers certification on behalf of DKG's certification system.
• European Cancer Centres (ECC)strategicStrategic or Co-development PartnerInternational certification program managed through European Cancer Centres network, enabling certification of oncological care facilities outside Germany since 2017.
• Movember FoundationminorStrategic or Co-development PartnerInternational men's health organization collaborating on PCO-Study (Prostate Cancer Outcome) data analysis. Movember published report based on data from DKG-certified prostate cancer centers over 9 years.
• Bundesverband Prostatakrebs Selbsthilfe (BPS)minorStrategic or Co-development PartnerGerman Prostate Cancer Self-Help Association collaborating on PCO-Study and patient-reported outcomes research.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• IQTIG (Institut für Qualitätssicherung und Transparenz im Gesundheitswesen): IQTIG is the German federal institute for healthcare quality assurance that develops quality indicators and audit procedures used across the German healthcare system. It is directly comparable because it also defines and operates quality-indicator frameworks for German healthcare facilities alongside OnkoZert's DKG programs.
• European Cancer Centres (ECC): ECC is the international oncology certification network through which OnkoZert already certifies ~100 international facilities; it is comparable as the platform owner for cross-border oncology accreditation that competes for the same international hospital segment.
• Kooperationsgemeinschaft Mammographie GbR: This is the German mammography-screening quality assurance body that certifies screening centers and operates a mandated QA program. It is a direct functional analogue: a German, mandated, center-certification organization in a clinical specialty.

Broad incumbents

• Joint Commission International (JCI): JCI is the largest global healthcare accreditation body, accrediting hospitals and specialty programs worldwide. While not oncology-specific, it is the closest functional analogue to OnkoZert's role as a third-party healthcare certification institute and competes for the same hospital accreditation budgets.
• TÜV SÜD Management Service: TÜV SÜD is a major German and international certification body that audits management systems and clinical/service quality across healthcare and other regulated industries. It represents the broader incumbent pool of accredited certification institutes that could in principle administer DKG-style oncology certifications.
• LGA InterCert GmbH: LGA InterCert is a German accreditation and certification body offering healthcare, quality, and environmental certifications. It is a comparable third-party certification provider operating in the same German healthcare market as OnkoZert.
• DQS Medizinprodukte GmbH: DQS is a leading German-accreditation certification body issuing ISO 13485, ISO 9001, and healthcare-related certifications. It is comparable as a competitor or back-up certification institute that hospitals engage for quality management audits in Germany.

Others

• ClarData GmbH: ClarData is OnkoZert's wholly-owned IT subsidiary developing the OncoBox and Clara software platforms. It is included as an adjacent ecosystem participant: a clinical-data software vendor whose tooling sits beneath OnkoZert's certification process.
• OnkoZert subsidiaries / DKG certification committees: Deutsche Krebsgesellschaft (DKG), OnkoZert's mandate partner, operates the certification committees that define audit requirements. Included as the principal counterparty governing OnkoZert's mandate; not a competitive peer but a structural relationship benchmark for similar governance elsewhere.

Regional players

• National Accreditation Board for Hospitals and Healthcare Providers (NABH): NABH operates hospital and healthcare accreditation programs in India, including oncology-relevant standards. It is a regional analogue: a nationally mandated accreditation institute for hospitals that mirrors OnkoZert's relationship with DKG in Germany.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/onkozertneuulm
• LinkedInlinkedin.com/company/onkozert

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OnkoZert